Targeting the microbiome in Crohn's disease

被引:4
作者
Borody, Thomas J. [1 ]
Dolai, Sibasish [1 ]
Gunaratne, Anoja W. [1 ]
Clancy, Robert L. [1 ]
机构
[1] Ctr Digest Dis, Res Dept, Five Dock, Australia
关键词
Anti-mycobacterial therapy; Crohn's disease; Crohn's strictures; dysbiosis; fecal microbiota transplantation; gut microbiome; inflammatory bowel disease; Mycobacterium avium subspecies paratuberculosis (MAP); profound remission; AVIUM SUBSPECIES PARATUBERCULOSIS; INFLAMMATORY-BOWEL-DISEASE; MACROLIDE-CLOFAZIMINE COMBINATION; ANTIBIOTIC-THERAPY; MYCOBACTERIUM-PARATUBERCULOSIS; RIFABUTIN; PATHOGENESIS; MAP; CD;
D O I
10.1080/1744666X.2022.2093186
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:873 / 877
页数:5
相关论文
共 50 条
  • [41] Targeting mucosal healing in Crohn's disease: what the clinician needs to know
    Klenske, Entcho
    Bojarski, Christian
    Waldner, Maximilian
    Rath, Timo
    Neurath, Markus F.
    Atreya, Raja
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2019, 12
  • [42] Antibiotic Therapy for Active Crohn's Disease Targeting Pathogens: An Overview and Update
    Iaquinto, Gaetano
    Mazzarella, Giuseppe
    Sellitto, Carmine
    Lucariello, Angela
    Melina, Raffaele
    Iaquinto, Salvatore
    De Luca, Antonio
    Rotondi Aufiero, Vera
    ANTIBIOTICS-BASEL, 2024, 13 (02):
  • [43] Targeting IL-23 in Crohn's disease
    Sedda, Silvia
    Bevivino, Gerolamo
    Monteleone, Giovanni
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2018, 14 (11) : 907 - 913
  • [44] Is There a Link Between H-Pylori and the Epidemiology of Crohn's Disease?
    Shah, Ayesha
    Talley, Nicholas J.
    Walker, Marjorie
    Koloski, Natasha
    Morrison, Mark
    Burger, Daniel
    Andrews, Jane M.
    McGuckin, Michael
    Jones, Mike
    Holtmann, Gerald
    DIGESTIVE DISEASES AND SCIENCES, 2017, 62 (09) : 2472 - 2480
  • [45] Confounding effects of microbiome on the susceptibility of TNFSF15 to Crohn's disease in the Ryukyu Islands
    Nakagome, Shigeki
    Chinen, Hiroshi
    Iraha, Atsushi
    Hokama, Akira
    Takeyama, Yasuaki
    Sakisaka, Shotaro
    Matsui, Toshiyuki
    Kidd, Judith R.
    Kidd, Kenneth K.
    Said, Heba S.
    Suda, Wataru
    Morita, Hidetoshi
    Hattori, Masahira
    Hanihara, Tsunehiko
    Kimura, Ryosuke
    Ishida, Hajime
    Fujita, Jiro
    Kinjo, Fukunori
    Mano, Shuhei
    Oota, Hiroki
    HUMAN GENETICS, 2017, 136 (04) : 387 - 397
  • [46] Oral Microbiome of Crohn's Disease Patients With and Without Oral Manifestations
    Hu, Shijia
    Mok, John
    Gowans, Michelle
    Ong, David E. H.
    Hartono, Juanda Leo
    Lee, Jonathan Wei Jie
    JOURNAL OF CROHNS & COLITIS, 2022, 16 (10) : 1628 - 1636
  • [47] Crohn’s disease
    Malathi Sathiyasekaran
    So. Shivbalan
    The Indian Journal of Pediatrics, 2006, 73 (8) : 723 - 729
  • [48] Crohn's disease
    Ballester Ferre, Maria Pilar
    Maia Bosca-Watts, Marta
    Minguez Perez, Miguel
    MEDICINA CLINICA, 2018, 151 (01): : 26 - 33
  • [49] Fecal Microbial Transplant Effect on Clinical Outcomes and Fecal Microbiome in Active Crohn's Disease
    Suskind, David L.
    Brittnacher, Mitchell J.
    Wahbeh, Ghassan
    Shaffer, Michele L.
    Hayden, Hillary S.
    Qin, Xuan
    Singh, Namita
    Damman, Christopher J.
    Hager, Kyle R.
    Nielson, Heather
    Miller, Samuel I.
    INFLAMMATORY BOWEL DISEASES, 2015, 21 (03) : 556 - 563
  • [50] Aspecific ileitis: Crohn’s disease or not Crohn’s disease? A prospective study
    Cristina Bezzio
    Ilaria Arena
    Massimo Devani
    Barbara Omazzi
    Gianpiero Manes
    Simone Saibeni
    International Journal of Colorectal Disease, 2017, 32 : 1025 - 1028